Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis.
Shimizu
Yuko
Y
Yokoyama
Kazumasa
K
Misu
Tatsuro
T
Takahashi
Toshiyuki
T
Fujihara
Kazuo
K
Kikuchi
Seiji
S
Itoyama
Yasuto
Y
Iwata
Makoto
M
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007370:Interferon Type I / Q000009:adverse effects* / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D009187:Myelitis / Q000150:complications* / Q000188:drug therapy*; D009471:Neuromyelitis Optica / Q000150:complications* / Q000188:drug therapy*; D011994:Recombinant Proteins; D013116:Spinal Cord / Q000473:pathology
D007166:Immunosuppressive Agents; D007370:Interferon Type I; D011994:Recombinant Proteins; D001379:Azathioprine